Azenta, Inc. × UK Biocentre Limited
Azenta, through its UK subsidiary, acquired UK Biocentre for a total consideration of £20.5 million. [37] This price includes up to £1.8 million in contingent milestone payments. [35, 37] The acquisition is a strategic move to establish a European hub for Azenta's Sample Repository Services and expand its biorepository capabilities in the region. [35, 51]
The asset
Acquisition of all issued and outstanding shares of UK Biocentre, a provider of sample management, storage, and high-throughput sample processing services.
The record
- Seller status
- Going concern
- Sector
- Biobanking and sample management
- Modalities
- biospecimens, sample_data
- Jurisdiction
- UK
What it means if you hold data
The acquisition highlights the strategic value of physical biobanking infrastructure and sample management services as foundational assets for the life sciences ecosystem. It reflects a trend of consolidation to provide end-to-end solutions, from sample collection and storage to processing and analysis, on a global scale. [38, 51]